Related by context. All words. (Click for frequent words.) 73 acute peripheral arterial 72 alfimeprase 69 BAY #-# 69 occlusion PAO 69 rNAPc2 69 phase IIb clinical 68 Methylnaltrexone 68 Pivotal Trial 68 fosbretabulin 68 Pivotal Phase III 68 Degarelix 68 Daclizumab 68 DU #b 67 Aflibercept 67 Mipomersen 67 TYZEKA 67 Phase III Clinical Trial 67 Pivotal Phase 67 Phase IIb clinical trials 67 interferon beta 1b 67 Vandetanib 67 xanthine oxidase inhibitor 67 catheter occlusion 67 Apixaban 67 Microplasmin 67 docetaxel Taxotere ® 67 Desmoteplase 67 Factor VIIa 67 EVIZON TM 67 Resten NG 67 Safinamide 66 Squalamine 66 HuMax EGFr 66 MKC# MKC# PP 66 reslizumab 66 Boceprevir 66 Dasatinib 66 Proxinium TM 66 Phase IIIb 66 edifoligide 66 Inhalation Solution 66 Phase III Pivotal 66 Glypromate 66 ZOLINZA 66 Deforolimus 66 ADP receptor antagonist 66 TACI Ig 66 Ridaforolimus 66 PRT# 66 CCX# 66 investigational humanized monoclonal antibody 66 IMC A# 66 Traficet EN 66 IMC #B 66 Meets Primary Endpoint 66 darapladib 66 Sapacitabine 66 VAPRISOL 66 EOquin TM 66 methylnaltrexone 66 Phase 2a Clinical Trial 66 Rivaroxaban 66 Fondaparinux 66 oral prodrug 66 DAPT 66 Pirfenidone 65 Phase III Clinical Trials 65 pertuzumab 65 riociguat 65 Icatibant 65 Dapagliflozin 65 cilengitide 65 peripherally acting 65 mertansine 65 TBC# 65 Tezampanel 65 Cetrorelix 65 Tanespimycin 65 IAP inhibitor 65 TELINTRA 65 Fibrin Pad 65 RELOVAIR ™ 65 Acute Ischemic Stroke 65 JAK inhibitor 65 Plasmin 65 Azedra 65 Vicriviroc 65 AEG# 65 Enzastaurin 65 oral anticoagulant 65 AZILECT R 65 tasocitinib 65 Pivotal Clinical Trial 65 Golimumab 65 corticosteroid dexamethasone 65 Tesetaxel 65 MNTX 65 antiplatelet agent 65 acyclovir Lauriad R 65 alvimopan 65 Saxagliptin 65 CBLC# 65 CD# monoclonal antibody 65 Viprinex 65 Epratuzumab 65 vidofludimus 65 Amrubicin 65 investigational monoclonal antibody 65 topically administered 65 TREDAPTIVE 65 Eculizumab 65 Bucindolol 65 sorafenib Nexavar 65 inhibitor RG# 65 angiogenesis inhibitor 65 verteporfin 65 Civacir 65 BRIM2 65 CIMZIA TM 65 Glatiramer Acetate 65 alefacept 65 Ocrelizumab 64 Dalbavancin 64 sorafenib tablets 64 MAGE A3 ASCI 64 Pertuzumab 64 phase IIb trial 64 thrombolytic agent 64 direct thrombin inhibitor 64 catheter occlusion CO 64 Ambrisentan 64 Clolar ® 64 Vidaza azacitidine 64 Valsartan 64 Zenvia Phase III 64 elotuzumab 64 ORENCIA R 64 Ranolazine 64 SinuNase TM 64 lapatinib Tykerb 64 Pimavanserin 64 gefitinib Iressa 64 Onco TCS 64 cangrelor 64 RhuDex 64 otelixizumab 64 ularitide 64 Intravitreal 64 Lixivaptan 64 Phase 2b Clinical Trial 64 PrevOnco 64 rFVIIa 64 Nexavar sorafenib 64 terlipressin 64 PROMACTA 64 Xanafide 64 lomitapide 64 Abciximab 64 Pafuramidine 64 GAMMAGARD 64 Rilonacept 64 phase IIa clinical 64 Phase Ib II 64 SCH # 64 direct thrombin inhibitors 64 Fibrillex TM 64 Fidaxomicin 64 Pemetrexed 64 IL# PE#QQR 64 opioid induced bowel dysfunction 64 tezampanel 64 ocrelizumab 64 PrevOnco ™ 64 HuLuc# 64 RSD# 64 Angiotensin Converting Enzyme 64 HuMax CD4 64 YONDELIS 64 PSN# [002] 64 intranasal formulation 64 platelet inhibitor 64 Phase IIb Trial 64 mild vasodilator 64 6R BH4 64 Omacetaxine 64 Clinical Trial Evaluating 64 Pixantrone 64 anticancer compound 64 Vaprisol 64 Vernakalant 64 XmAb# 64 Phase #b/#a 64 Liprotamase 64 hormone LHRH antagonist 64 Phase III Trial 64 Genasense ® oblimersen 64 herpetic keratitis 64 clazosentan 64 CINTREDEKIN BESUDOTOX 64 Biolimus A9 64 Exemestane 64 BrachySil TM 64 icatibant 64 Pradefovir 64 liposomal formulation 64 TELCYTA 64 Bortezomib 64 GW# [003] 64 Dacogen decitabine 64 Hydroxyurea 64 Ofatumumab 64 visilizumab 64 rituximab Rituxan 64 Phase #b/#a trial 64 atacicept 63 cediranib 63 GGF2 63 Zorbtive TM 63 Vascugel ® 63 thalidomide Thalomid 63 metastatic colorectal 63 lidocaine hydrochloride monohydrate powder 63 TLK# 63 Phase #b/#a clinical 63 Genentech Rituxan 63 Cloretazine VNP#M 63 TM Drug Eluting 63 nucleoside analog 63 Lubiprostone 63 CorVue ™ 63 INTEGRILIN R 63 anticlotting drugs 63 cinacalcet 63 prospective randomized multicenter 63 oxypurinol 63 DEXILANT 63 Cleviprex TM clevidipine 63 Romiplostim 63 Motesanib 63 BRAF inhibitor 63 Temsirolimus 63 Severe Sepsis 63 lumiliximab 63 SUTENT 63 PSMA ADC 63 LEUKINE 63 mu opioid receptor antagonist 63 Anti VEGF 63 MEK inhibitor 63 HGS# 63 selective modulator 63 Archexin 63 ALGRX 63 ISTODAX 63 trial evaluating PRX# 63 Oral Fingolimod 63 Pyridorin 63 ZACTIMA 63 Curaxin CBLC# 63 brivaracetam 63 GSK# [001] 63 QLT# 63 NDA Submission 63 tecarfarin 63 CYT# QbG# 63 ZYBRESTAT TM 63 muraglitazar 63 Rituximab 63 Maribavir 63 Phenoptin 63 Sym# 63 NV1FGF 63 INTEGRILIN 63 Ranibizumab 63 Tacrolimus 63 Ticagrelor 63 noninfectious uveitis 63 inhaled iloprost 63 TORISEL 63 vemurafenib 63 LEP ETU 63 R#/MEM 63 Tolvaptan 63 Phase IIB 63 FOLOTYN ® 63 THR beta agonist 63 Dupuytren Contracture 63 infliximab Remicade 63 tiapamil 63 cathepsin K inhibitor 63 proteasome inhibitor 63 Cethromycin 63 Eltrombopag 63 receptor tyrosine kinase inhibitor 63 Nuvion 63 Prospective Randomized 63 Interferon beta 1a 63 Hedgehog Pathway Inhibitor 63 Bosutinib 63 Pivotal Study 63 Aliskiren 63 Pegloticase 63 REG1 63 APTIVUS 63 Phase IIb Clinical Trial 63 pan HDAC inhibitor 63 ESBA# 63 Angiocept 63 Personalized Immunotherapy 63 Vascugel 63 gastrointestinal stromal tumors GIST 63 NeuroSTAT ® 63 inhaled formulation 63 subcutaneous formulation 63 Eluting Stent 63 Ceflatonin 63 CCX# B 63 posaconazole 63 Ataluren 63 acetonide FA 63 cannabinor 63 Cancidas 63 investigational protease inhibitor 63 malignant ascites 63 factor Xa inhibitor 63 Carfilzomib 63 Bicifadine 63 amphotericin B 63 acting thrombolytic 63 BrachySil 63 Blinatumomab 63 MIST II 63 phase IIb 63 Novel Oral 63 delivers fluocinolone acetonide FA 63 GLP1 agonist 63 Panzem R 63 axitinib 63 tafamidis 63 fostamatinib 63 MYDICAR ® 63 ancrod 63 AMEVIVE 63 targeted radiotherapeutic 63 olmesartan 63 sodium glucose cotransporter 63 Bremelanotide 63 eprotirome 63 factor Xa 63 Lisofylline 63 ALN HPN 63 OvaRex ® MAb 63 FASLODEX 63 Firazyr 63 Abbokinase 63 FDA APPROVES 63 BCR ABL inhibitor 63 EchoCRT 63 teduglutide 63 cetuximab Erbitux R 63 mGluR5 negative 63 Panitumumab 63 Hepatocellular Carcinoma HCC 63 systemically administered 63 cardio renal 63 Arranon 63 lanreotide 63 clevidipine 63 Onconase 63 ULORIC 63 OZURDEX ® 63 Betaferon R 63 either acutely decompensated 62 romiplostim 62 BAL# [002] 62 INCB# [001] 62 Chemophase 62 Tasimelteon 62 ulimorelin 62 rt PA 62 severe gastroparesis 62 lucinactant 62 Cethrin 62 PEGylated Fab fragment 62 albiglutide 62 Teriflunomide 62 methylnaltrexone bromide 62 DUROS 62 postoperative ileus POI 62 ACV1 62 volociximab 62 ganetespib 62 Phase Ib clinical 62 SinuNase ™ 62 mapatumumab 62 orally inhaled 62 dexpramipexole 62 Motavizumab 62 Initiates Clinical 62 Febuxostat 62 HDAC Inhibitor 62 luteinizing hormone releasing 62 PDE4 inhibitor 62 Darusentan 62 Myelodysplastic Syndrome MDS 62 dyskinesia PD LID 62 midstage clinical trials 62 MULTAQ 62 aflibercept VEGF Trap 62 antifibrotic 62 Zileuton 62 Bezielle 62 multicenter randomized placebo controlled 62 BLP# Liposome Vaccine 62 Denufosol 62 Arixtra 62 SinuNase 62 calcineurin inhibitor 62 Everolimus 62 selective adenosine 62 beta 1a 62 Pazopanib 62 ATL# [002] 62 diarrhea predominant irritable 62 Toremifene 62 Noxafil 62 cysteamine bitartrate 62 MGd 62 AGILECT R 62 Torisel 62 Exherin TM 62 Aclidinium 62 daclizumab 62 investigational antiplatelet agent 62 ORENCIA ® 62 Zirgan 62 Elotuzumab 62 REVLIMID lenalidomide 62 long acting muscarinic 62 antiarrhythmic drug 62 GALNS 62 Cloretazine 62 trastuzumab DM1 T DM1 62 orally administered inhibitor 62 Tocilizumab 62 Vicinium TM 62 RSD# oral 62 Initiate Phase 62 phase III isavuconazole 62 eltrombopag 62 SUTENT ® 62 Cand5 62 factor Xa inhibitors 62 generation purine nucleoside 62 PROTEGE 62 INS# [001] 62 teriflunomide 62 Leukine 62 BYSTOLIC 62 Elagolix 62 Randomized Phase 62 rosuvastatin #mg 62 EVIZON 62 Cetuximab Erbitux 62 selective A2A adenosine receptor 62 Panzem R NCD 62 Androxal TM 62 randomized Phase IIb 62 IRX 2 62 multicenter Phase II 62 MYCAMINE 62 Enkephalin 62 Coronary Stent 62 FTY# 62 recombinant tissue plasminogen 62 Lacosamide 62 Specifid 62 E2F Decoy 62 Randomized Evaluation 62 sodium thiosulfate STS 62 tanespimycin 62 Trandolapril 62 Velcade bortezomib 62 oral ridaforolimus 62 CTAP# Capsules 62 plasma kallikrein inhibitor 62 Medoxomil 62 blood clot dissolver 62 Kepivance 62 treprostinil 62 CRMD# 62 Vilazodone 62 Radezolid 62 selective phosphodiesterase 62 vapreotide acetate 62 Advagraf 62 Phase Ib study 62 Ceflatonin ® 62 BARACLUDE R 62 Asentar 62 Edoxaban 62 humanized monoclonal antibody 62 Bosentan 62 MYDICAR 62 Phase IIIb clinical 62 multicenter Phase 62 double blinded placebo 62 cobiprostone 62 antibody MAb 62 gamma secretase inhibitor 62 Trastuzumab 62 invasive candidiasis 62 bevacizumab Avastin ® 62 multicenter Phase III 62 Urocortin 2 62 StemEx 62 ziconotide 62 ALN TTR# 62 Fenretinide 62 Initiates Enrollment 62 R#/MEM # 62 sitaxsentan 62 CIMZIA TM certolizumab pegol 62 ATL# [001] 62 Ventavis 62 investigational pharmacologically unique 62 DXL# 62 Telmisartan 62 Central Retinal Vein 62 echinocandin 62 JZP 62 forodesine 62 PEG SN# 62 Corlux 62 rilonacept 62 regorafenib 62 angiotensin receptor blocker ARB 62 Cloretazine ® 62 metastatic malignant 62 ATPace TM 62 Dose Ranging Study 62 Certolizumab 62 Eluting Coronary Stent System 62 Zybrestat 62 Nebulized 62 uricase 62 octreotide acetate 62 sunitinib malate 62 prospective multicenter randomized 62 Achieves Primary Endpoint 62 Gleevec imatinib mesylate 62 Vidofludimus 62 systemic RNAi therapeutic 62 Losartan 62 huC# DM4 62 Nesiritide 62 midstage clinical 62 INTEGRILIN ® 62 COREG CR 62 Phase IIa trials 62 EndoTAG TM -1 62 cetuximab Erbitux 62 Chrysalin 62 docetaxel Taxotere R 62 octreotide implant 62 Solulin 62 Irinotecan 62 Certolizumab pegol 62 octreotide 62 selective androgen receptor modulator 62 GSK# [002] 62 Pivotal Trials 62 UPLYSO 62 unfractionated heparin UFH 62 including eniluracil ADH 62 INCB# [003] 62 Dabigatran etexilate 62 Moxifloxacin 62 Relovair 62 Candesartan 62 ZD# [001] 62 Natalizumab 62 serotonin norepinephrine reuptake inhibitor 62 novel VDA molecule 62 NOXAFIL 61 LY# [002] 61 CytoFabTM 61 placebo controlled clinical 61 GRNCM1 61 rFVIIIFc 61 sirolimus 61 CIMZIA ™ 61 RhuDex ® 61 BENICAR 61 Betrixaban 61 Liraglutide 61 PPAR gamma agonist 61 KRN# 61 Raptiva ® 61 eniluracil 61 Luveniq 61 CONTRAINDICATIONS 61 ketolide antibiotic 61 multi kinase inhibitor 61 Avanafil 61 Efficacy Trial 61 Ecallantide 61 humanized monoclonal 61 Alvesco R 61 VA# [002] 61 laropiprant 61 immunotherapeutic vaccine 61 virus HCV protease inhibitor 61 ximelagatran 61 Belatacept 61 hormone agonist 61 MEVACOR 61 somatostatin analogue 61 Vimpat R 61 nab paclitaxel 61 Patient Enrollment 61 Aptivus ® 61 VEGF Trap 61 AERx R 61 deforolimus 61 Belimumab 61 ospemifene 61 PEG uricase 61 ALN PCS 61 EXPAREL TM 61 CYT# potent vascular disrupting 61 intravenous methylnaltrexone 61 Muraglitazar 61 Hormone Refractory Prostate Cancer 61 Actimmune ® 61 dihydrochloride 61 RLY# 61 tyrosine kinase inhibitor 61 PKC# 61 efalizumab 61 mTOR inhibitor 61 Elvitegravir 61 Diabetic Macular Edema DME 61 RoACTEMRA 61 incyclinide 61 Excellarate TM 61 occlusion CRVO 61 Neulasta ® 61 postoperative ileus 61 ABILIFY ® 61 Liposomal 61 AAG geldanamycin analog 61 Recombinant Human 61 PEGylated 61 Zyclara 61 Pralatrexate 61 Hsp# Inhibitor 61 Perifosine 61 Dacogen injection 61 Epanova 61 squalamine 61 C1 INH 61 RECOTHROM R 61 XL# XL# XL# 61 NAVISTAR R 61 Entereg 61 Aerosurf 61 Cloretazine R 61 Adlea 61 refractory gout 61 Telavancin 61 dasatinib Sprycel ® 61 Ascendra 61 blinded randomized placebo controlled 61 NP2 Enkephalin 61 EDEMA3 61 alvespimycin 61 phase IIIb 61 Xelox 61 pain palliation 61 TG# [003] 61 Drug Eluting Stent System 61 Nexavar ® 61 fondaparinux sodium 61 LEVAQUIN 61 TYKERB 61 vandetanib 61 TNF Tumor Necrosis Factor 61 abacavir Ziagen 61 CDK inhibitor 61 APEX PD 61 Octreotide 61 IgG1 monoclonal antibody 61 ReoPro 61 microtubule inhibitor 61 Crizotinib 61 Iloperidone 61 ACTEMRA TM 61 BENLYSTA ® 61 enzastaurin 61 thymalfasin 61 Glufosfamide 61 Phase #/#a 61 motesanib 61 EP #R 61 PRoFESS 61 PRTX 61 LAF# 61 varespladib 61 IMA# 61 MKC# 61 CB2 selective receptor agonist 61 evaluating tivozanib 61 tacrolimus ointment 61 5 HT3 antagonist 61 Elesclomol 61 OncoVex 61 Tarceva TM 61 small molecule Hedgehog 61 phase IIb study 61 BRILINTA 61 AERx ® 61 SNT MC# 61 Ixempra 61 FVIIa 61 Enzyme Replacement Therapy 61 HGS ETR1 61 intravesical instillation 61 selective inhibition 61 systemic hypotension 61 pioglitazone HCl 61 EGS# 61 tolevamer 61 Annamycin 61 HCD# [002] 61 leukotriene pathway 61 Entereg R 61 Tolamba 61 Pharmacokinetics PK 61 PI3K/Akt pathway inhibitor 61 Catena ® 61 rolofylline 61 Initiates Phase III 61 ALN TTR 61 post operative ileus 61 Phase 2b clinical trials 61 ONCONASE R 61 ELND# 61 paclitaxel poliglumex 61 R Saizen R 61 NEUPOGEN 61 sipuleucel T 61 Exelixis XL# 61 PEGylated anti 61 cromolyn sodium 61 induced macular edema 61 superficial bladder cancer 61 PEGINTRON TM 61 Phase Ib clinical trials 61 LHRH antagonist 61 TAFA# 61 Oral Insulin 61 Perforomist ™ Inhalation Solution 61 Fludara ® 61 Ozarelix 61 Study Evaluating 61 acadesine 61 XYOTAX TM 61 HQK 61 Teriparatide 61 vorinostat 61 Tyrima 61 ranolazine 61 Sorafenib 61 sublingual tablets 61 OMS#HP 61 aerosolized KL4 surfactant 61 OMNARIS HFA 61 orally inhaled migraine 61 SAR# [002] 61 CEQ# 61 APTIVUS r 61 aripiprazole Abilify 61 recurrent glioma 61 retinal vein occlusion induced 61 intravitreal injection 61 ALVESCO ® 61 small molecule activators 61 Carvedilol 61 GVAX 61 recurrent glioblastoma multiforme 61 bolus dose 61 chimeric monoclonal antibody 61 glatiramer 61 BRINAVESS 61 Patients Treated With 61 GEM OS2 61 velafermin 61 LymphoStat B belimumab 61 menadione 61 TNF alpha inhibitor 61 Mycograb 61 adalimumab Humira 61 TRO# 61 Ophena TM 61 Revimmune 61 post herpetic neuralgia PHN 61 Pathway Inhibitor 61 esomeprazole Nexium 61 SEPET TM 61 Granulocyte Colony Stimulating Factor 61 Crofelemer 61 combretastatin A4 phosphate CA4P 61 neuroprotectant 61 erlotinib Tarceva ® 61 histone deacetylase HDAC inhibitor 61 Cotavance 61 Zometa zoledronic acid 61 RezularTM 61 NP2 61 ADVANCE PD 61 bicifadine 61 REP# 61 selective antagonist 61 calcineurin inhibitors 61 Faropenem 61 phase IIa 61 pseudobulbar affect PBA 61 Zarnestra 61 vinorelbine tartrate 61 ocular hypertension 61 Prostate AdenoCarcinoma Treatment 61 Zingo TM 61 Bendamustine 61 SomatoKine 61 Unit Dose Budesonide 61 QVA# 61 Alocrest 61 topical ophthalmic 61 Fodosine 61 oral rivaroxaban 61 topical diclofenac 61 drug ISA# 61 STRIDE PD 61 palonosetron 61 LUMINATE 61 orBec 61 intravesical infusion therapy 61 LibiGel ® 61 Phase IIb trials 61 reteplase 61 sd rxRNA 61 endothelin receptor antagonists 61 Celecoxib 61 AVE# 61 alfa 2a 61 Ceflatonin R 61 midstage trials 61 Anidulafungin 61 Cangrelor 61 T Pred 61 PHASE III 60 Vitaxin 60 Phase Ib IIa 60 HCV RESPOND 2 60 Prosaptide 60 AVASTIN 60 Anturol TM 60 Iluvien ® 60 BENICAR HCT 60 Nanobody 60 Factor Xa inhibitor 60 Adenoma Prevention 60 renin inhibitor 60 AEGR 60 TriRima 60 RE LY 60 TYGACIL 60 Talabostat 60 diabetic gastroparesis 60 kidney urologic 60 ILUVIEN ® 60 motavizumab 60 bisoprolol 60 polymerase inhibitor 60 injectable formulation 60 Zenapax 60 baminercept 60 VFEND 60 TOLAMBA 60 Linaclotide 60 mGluR2 positive 60 alagebrium 60 Betaseron ® 60 protein tyrosine phosphatase 1B 60 Survivin antagonist 60 Simulect 60 PROCHYMAL 60 Zomig 60 PRISTIQ 60 Zolinza 60 HCV protease inhibitor 60 nimodipine 60 GV# [001] 60 ritonavir boosted 60 Fabry Disease 60 Sudhir Agrawal D.Phil 60 Proquin XR 60 lexidronam injection 60 Viramidine 60 cetrorelix pamoate 60 Nexium esomeprazole 60 MTP inhibitor 60 DNA intercalator 60 ONTAK 60 oral cladribine 60 Spheramine 60 HuMax CD# 60 budesonide foam 60 DEB# 60 Myoblast 60 CA4P 60 CIMZIA R 60 arterial thrombosis 60 Betaferon ® 60 cerebral vasospasm 60 rhIGF-I/rhIGFBP-3 60 prospective multicenter 60 dexlansoprazole 60 mesylate 60 Raltegravir 60 alkylating agent 60 Olaparib 60 Acute Decompensated Heart Failure 60 glatiramer acetate 60 CD3 monoclonal antibody 60 Initiates Phase II 60 Nasulin 60 dosage regimens 60 LHRH antagonists 60 canagliflozin 60 efficacy tolerability 60 Ziprasidone 60 BRIM3 60 novel oral anticoagulant 60 Troxatyl 60 EGFR HER2 60 Olmesartan 60 Certican 60 Indaflex TM 60 aurora kinase 60 Stedivaze 60 anti CD3 antibody 60 CRVO 60 AKT inhibitor 60 Initiated Phase 60 Sevelamer 60 vivo validation 60 STEDESA 60 midstage studies 60 Vascular Disrupting Agent 60 IIIa inhibitor 60 Medidur TM FA 60 eritoran 60 L BLP# 60 Plicera 60 oral dual endothelin 60 proteasome inhibitor bortezomib 60 oral salmon calcitonin 60 telbivudine 60 phase Ib 60 neratinib 60 Medtronic CoreValve 60 antiarrhythmic drugs 60 eluting stent 60 Aurora Kinase 60 fondaparinux 60 opioid receptor antagonist 60 LUX Lung 60 Kamada AAT 60 synthetic retinoid 60 Phase 2a trial 60 azilsartan medoxomil 60 peg interferon 60 DPP4 inhibitor 60 2 methoxyestradiol 60 metformin HCl 60 DP b# 60 Universal Flu Vaccine 60 sunitinib Sutent 60 Granted Orphan Drug 60 Lisofylline LSF 60 PRIALT 60 placebo controlled Phase 60 Phase Ib 60 parecoxib 60 tezampanel NGX# 60 Completes Patient Enrollment 60 Besivance